Corteva (NYSE:CTVA) Stock Bumped Up to “Overweight” by JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Corteva (NYSE:CTVA) from a neutral rating to an overweight rating in a research report released on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has $19.00 price objective on the stock.

A number of other analysts also recently weighed in on CTVA. Oppenheimer set a $17.00 target price on shares of Corteva in a report on Monday. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $101.00 price objective on shares of Corteva in a research note on Monday, August 3rd. Citigroup upped their price objective on Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research report on Thursday, September 17th. Finally, Argus reaffirmed a “buy” rating and issued a $91.00 price objective on shares of Corteva in a research note on Friday, September 18th. Fifteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus price target of $73.95.

Corteva Trading Up 12.2%

CTVA stock opened at $13.90 on Tuesday. The firm has a fifty day moving average price of $75.82 and a 200 day moving average price of $79.64. Corteva has a fifty-two week low of $11.74 and a fifty-two week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $9.27 billion, a PE ratio of 9.20, a price-to-earnings-growth ratio of 0.38 and a beta of 0.57.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the prior year, the firm earned $2.20 earnings per share. Corteva’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 5.2%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of CTVA. Parkside Financial Bank & Trust boosted its holdings in Corteva by 3.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after purchasing an additional 116 shares during the last quarter. William B. Walkup & Associates Inc. increased its holdings in shares of Corteva by 2.9% during the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after buying an additional 126 shares during the last quarter. HB Wealth Management LLC lifted its holdings in Corteva by 0.5% in the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock valued at $2,018,000 after acquiring an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC lifted its holdings in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after acquiring an additional 133 shares during the last quarter. Finally, AdvisorNet Financial Inc grew its position in Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after acquiring an additional 135 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight and set a $19 price target, arguing that the stock is undervalued after the Vylor spin-off. The target implies substantial upside from recent trading levels and was the primary catalyst behind the rally. JPMorgan Upgrades Corteva to Overweight
• Positive Sentiment: Bank of America maintained a Buy rating and an $18 price target. The firm cited Corteva’s new product launches, innovation and expectations for tighter agricultural markets in 2027, which could help offset pressure on older products. Corteva remains a buy, BofA says
• Positive Sentiment: The post-spin-off structure may improve investor focus. Corteva is now a more concentrated crop-protection company, while the separation of Vylor could make the businesses easier to value independently and allow management to emphasize operational improvement and product innovation. Corteva rallies after analyst upgrade
• Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The upcoming report may provide the next major catalyst, particularly for evidence that new products are offsetting legacy-product weakness. Corteva announces third-quarter earnings date
• Negative Sentiment: A valuation report warned that Corteva could be overvalued after its recent advance, creating a potential short-term headwind if investors take profits or the company’s earnings fail to support the higher valuation. GF Value assessment of Corteva

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.